首页--医药、卫生论文--药学论文--药剂学论文--制剂学论文

Nanostructured Lipid Carrier Mediated Co-delivery of Quantum Dots and Paclitaxel to Tumour for Cancer Imaging and Therapy:a Multifunctional Nanoparticle Construct for Theragnostic Approach

Abstract第6-7页
Chinese abstract第8-23页
Chapter 1-General introdution第23-47页
    1.1 Statement第23-26页
    1.2 Literature review第26-46页
    1.3 Hypothesis第46页
    1.4 Aims第46-47页
Chapter 2-Formulation第47-52页
    2.1 Introduction第47-48页
    2.2 Materials第48-49页
    2.3 Animals第49页
    2.4 Establishment of H22 hepatocellular carcinoma mice model第49页
    2.5 Cell culture第49-50页
    2.6 Design第50页
    2.7 Preparation of co-loaded(PTX and QDs)NLC and blank NLC(b-NLC)第50-52页
        2.7.1 Method and materials第50-51页
        2.7.2 Results第51页
        2.7.3 Discussion第51-52页
Chapter 3-Process of optimising the formulation第52-53页
Chapter 4-PTX analytical method validation第53-60页
    4.1 Method and materials第53-56页
    4.2 Results(Original record;lab book no.0002924,Pages 62-69)第56-60页
Chapter 5-Physicochemical characterisation of co-loaded NLC第60-68页
    5.1 Particle size, polydispersitv and zeta potential measurements第60-63页
        5.1.1 Method and materials第60页
        5.1.2 Results第60-61页
        5.1.3 Discussion第61-63页
    5.2 Transmission electron microscopy(TEM)第63-64页
        5.2.1 Method and materials第63-64页
        5.2.2 Results第64页
        5.2.3 Discussion第64页
    5.3 Determination of encapsulation efficacy(EE)and drug loading(DL)第64-66页
        5.3.1 Method and materials第64-65页
        5.3.2 Results第65页
        5.3.3 Discussion第65-66页
    5.4 Stability studies第66-68页
        5.4.1 Method and materials第66页
        5.4.2 Results第66-67页
        5.4.3 Discussion第67-68页
Chapter 6-In vitro studies第68-80页
    6.1 In vitro drug release study第68-70页
        6.1.1 Method and materials第68-69页
        6.1.2 Results第69页
        6.1.3 Discussion第69-70页
    6.2 In vitro cytotoxicity studies第70-72页
        6.2.1 Method and materials第70-71页
        6.2.2 Results第71-72页
        6.2.3 Discussion第72页
    6.3 Apoptosis assessment by Annexin V-FITC/propidiun iodide(PI)assay第72-76页
        6.3.1 Method and materials第72-74页
        6.3.2 Results第74-75页
        6.3.3 Discussion第75-76页
    6.4 In vitro cellular uptake study第76-80页
        6.4.1 Method and materials第76-78页
        6.4.2 Results第78页
        6.4.3 Discussion第78-80页
Chapter 7- In-vivo and ex-vivo studies第80-94页
    7.1 In vivo therapeutic efficacy evaluation第80-85页
        7.1.1 Method and materials第80-82页
        7.1.2 Results第82-83页
        7.1.3 Discussion第83-85页
    7.2 In-vivo and Ex-vivo Fluorescence Optical Imaging abilities of the co-loaded NLC第85-88页
        7.2.1 Method and materials第85-86页
        7.2.2 Results第86-87页
        7.2.3 Discussion第87-88页
    7.3 Paclitaxel assay in major organs第88-91页
        7.3.1 Method and materials第88-89页
        7.3.2 Results第89-90页
        7.3.3 Discussion第90-91页
    7.4 Histopathological assessment by light microscopy第91-94页
        7.4.1 Method and materials第91-92页
        7.4.2 Results第92-93页
        7.4.3 Discussion第93-94页
Chapter 8-Conclusion and future perspective第94-95页
    8.1 Conclusion第94页
    8.2 Future perspective第94-95页
Chapter 9- References第95-109页
Chapter 10- Appendices第109-157页
    Appendix 1- Preparation and characterisation of downsized b-NLC第109-111页
    Appendix 2- Preparation and characterisation of optimisation of downsized PTX-NLC第111-113页
    Appendix 3- EE and DL data for co-loaded NLC (Original record;lab book no. 0002925,Page 15)第113-114页
    Appendix 4- Stability study data for co-loaded NLC (Original record;lab book no.0002927 , Page 19)第114-115页
    Appendix 5- In-vitro drug release data (Original record;lab book no.0002925,Pages 78-81)第115-119页
    Appendix 6- In-vitro cytotoxicity studies data (Original record;lab book no.0002926,Pages 24-38)第119-125页
    Appendix 7- Apoptosis data (Original record;lab book no.0002927, Pages 53-57)第125-128页
    Appendix 8-In-vitro cellular uptake data for co-loaded NLC (Original record;lab bookno.0002926, Page 94 & lab book no. 0002927,Page 23)第128-129页
    Appendix 9- In-vivo anti-tumour efficacy data for co-loaded NLC (Original record;labbook no.0002925.Pages 21-61)第129-149页
    Appendix 10- In-vivo and Ex-vivo Fluorescence Optical Imaging abilities ofthe co-loadedNLC data(Original record;lab book no. 0002925,Pages 62-70)第149-150页
    Appendix 11- Paclitaxel assay in major organs (Original record;lab book no.0002927,Pages 31-39)第150-154页
    Appendix 12- Histopathological assessment data for co-loaded NLC (Original record;labbook no. 0002925,Pages 86-100 & lab book no.0002926, Pages 1&2)第154-157页
Dedications第157-159页
Acknowledgements第159-162页
List of publications第162-163页
Published work第163-173页
学位论文评阅及答辩情况表第173页

论文共173页,点击 下载论文
上一篇:长链非编码RNA ROR对胃癌干细胞增殖和侵袭能力以及特性的功能研究
下一篇:TLR9在维持肠道完整性和抵抗鼠伤寒沙门氏菌感染中的作用和机制研究